Cerium Pharmaceuticals
Pharmaceutical ManufacturingView the employees at
Cerium Pharmaceuticals-
Semsi Burak Derkunt, PhD Chief Scientific Officer at Cerium Pharmaceuticals
-
Washington, District of Columbia, United States
-
Rising Star
-
Overview
Cerium Pharmaceuticals is dedicated to creating efficacious therapies for patients with kidney diseases. Cerium is currently focused on developing the first drug approved for a very rare kidney disease called Primary Membranous Nephropathy (PMN). There are approximately 75,000 PMN patients in the US and approximately 3,000 newly diagnosed PMN patients per year.